Compugen Ltd. Stock TEL AVIV STOCK EXCHANGE
Stocks
IL0010852080
Biotechnology & Medical Research
| Market Cap | 196M 0 171M 158M 148M 277M 18.5B 279M 1.88B 732M 9.1B 735M 719M 31.6B | P/E 2026 * |
-7.14x | P/E 2027 * | -7.24x |
|---|---|---|---|---|---|
| Enterprise Value | 196M 0 171M 158M 148M 277M 18.5B 279M 1.88B 732M 9.1B 735M 719M 31.6B | EV / Sales 2026 * |
20.8x | EV / Sales 2027 * | 12.2x |
| Free-Float |
97.92% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Compugen Ltd.
| 1 day | +10.90% |
| Manager | Title | Age | Since |
|---|---|---|---|
Eran Ophir
CEO | Chief Executive Officer | - | 2025-09-22 |
David Silberman
DFI | Director of Finance/CFO | 42 | 2024-08-14 |
Pierre Ferre
COO | Chief Operating Officer | 49 | 2023-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Anat Cohen-Dayag
CHM | Chairman | 59 | 2025-09-22 |
Gilead Halevy
BRD | Director/Board Member | 59 | 2018-06-10 |
Sanford Zweifach
BRD | Director/Board Member | 70 | 2018-06-10 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +10.90% | +2.00% | - | - | 190M | |
| +0.34% | +1.09% | -10.67% | -5.05% | 43.13B | |
| +1.73% | +3.59% | +318.08% | +564.04% | 34.65B | |
| +0.61% | +1.34% | +10.00% | +46.20% | 30.03B | |
| +0.02% | -5.93% | +8.45% | -21.44% | 28B | |
| -1.06% | -2.60% | +9.08% | +21.51% | 24.45B | |
| -1.23% | +2.11% | - | - | 14.34B | |
| -0.99% | -2.53% | +47.29% | +102.88% | 13.14B | |
| +1.54% | +0.16% | +6.69% | +8.89% | 12.53B | |
| +2.39% | +2.61% | +102.86% | +84.20% | 12.25B | |
| Average | +1.42% | -0.20% | +61.47% | +100.15% | 23.61B | |
| Weighted average by Cap. | +0.41% | -0.10% | +67.04% | +116.73% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 9.41M 0 8.23M 7.61M 7.1M 13.33M 890M 13.43M 90.42M 35.18M 437M 35.35M 34.58M 1.52B | 16.05M 0 14.02M 12.97M 12.11M 22.73M 1.52B 22.89M 154M 59.97M 746M 60.25M 58.95M 2.59B |
| Net income | -27.6M -0 -24.11M -22.3M -20.82M -39.08M -2.61B -39.37M -265M -103M -1.28B -104M -101M -4.45B | -28.01M -0 -24.48M -22.64M -21.13M -39.67M -2.65B -39.96M -269M -105M -1.3B -105M -103M -4.52B |
| Net Debt | - | - |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
